Sep 1, 2026 06:12AM
Aug 24, 2026 06:19AM
Aug 21, 2026 04:41PM
Jul 23, 2026 07:30AM
Jul 14, 2026 10:40AM
Jun 23, 2026 06:54AM
Mar 31, 2026 08:01AM Nuvectis Pharma to present NXP900 data at 2026 cancer research meeting
Feb 13, 2026 04:05PM
Dec 3, 2025 06:44AM
Oct 28, 2025 06:44AM
Aug 5, 2025 09:11AM
Aug 4, 2025 09:54AM
Jul 8, 2025 08:03AM
May 6, 2025 04:35PM Nuvectis Pharma, Inc. (NVCT) Tops Q1 EPS by 53c
Mar 17, 2025 01:08AM
Mar 4, 2025 08:02AM
Feb 5, 2025 09:02AM
Feb 4, 2025 04:05PM
Nov 14, 2024 07:01AM
Nov 5, 2024 04:05PM
Aug 29, 2024 08:01AM Nuvectis Pharma (NVCT) Announces Orphan Drug Designation Granted by the FDA for NXP800 for the Treatment of ARID1a-deficient Ovarian, Fallopian Tube, and Primary Peritoneal Cancers

456,957 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All